The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNIC.L Regulatory News (CNIC)

  • There is currently no data for CNIC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Capital Reduction

14 Aug 2020 17:23

RNS Number : 2442W
CentralNic Group PLC
14 August 2020
 

 

14 August 2020

CentralNic Group plc

("CentralNic" or "the Company" or "the Group")

 

Completion of Capital Reduction

 

 

CentralNic Group PLC (AIM: CNIC), the internet platform that derives revenue from the worldwide sales of internet domain names and related services, is pleased to announce that the Capital Reduction resolved by its Annual General Meeting on 4 June 2020 has been completed subsequent to its approval by the High Court and its registration by the Companies House effective 14 August 2020.

The Capital Reduction increases the Company's distributable reserves and facilitates making future distributions to its shareholders, including the payment of dividends. The Capital Reduction does not result in any cash outflow nor does it impact the Company's profits. There is no change in the number of shares in issue or their nominal value. No new share certificates are being issued because of the Capital Reduction. The Capital Reduction itself does not involve any distribution or repayment of capital or share premium by the Company and does not reduce the underlying net assets of the Company.

Ben Crawford, CEO of CentralNic, said: "It is an opportune time to undertake this Capital Reduction, thereby making the payment of dividends possible, should the Board decide at a future date that the financial performance of the Group and the economic environment indicate that issuing a dividend is the most appropriate action to benefit shareholders."

 

 

For further information:

CentralNic Group Plc

Ben Crawford, Chief Executive Officer

Don Baladasan, Group Managing Director

Michael Riedl, Chief Financial Officer

 

 +44 (0) 203 388 0600

Zeus Capital Limited (NOMAD and Joint Broker)

Nick Cowles / Jamie Peel (Corporate Finance)

John Goold / Rupert Woolfenden 

(Institutional Sales)

 

+44 (0) 161 831 1512

+44 (0) 203 829 5000

Stifel (Joint Broker)

Fred Walsh / Alex Price

+44 (0)20 7710 7600

 

 

Newgate Communications (for Media)

Bob Huxford

Tom Carnegie

Isabelle Smurfit

 

+44 (0) 203 757 6880

centralnic@newgatecomms.com

 

 

About CentralNic Group plc 

CentralNic (AIM: CNIC) is a London-based AIM-listed company which drives the growth of the global digital economy by developing and managing software platforms allowing businesses globally to buy subscriptions to domain names, used for their own websites and email, as well as for protecting their brands online. Its core growth strategy is identifying and acquiring cash-generative businesses in its industry with annuity revenue streams and exposure to growth markets and migrating them onto the CentralNic software and operating platforms. 

 

CentralNic operates globally with customers in almost every country in the world. It earns recurring revenues from the worldwide sales of internet domain names and other services on an annual subscription basis. 

 

For more information please visit: www.centralnicgroup.com 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUSANRRBUWAAR
Date   Source Headline
25th Apr 20237:00 amRNSResult of AGM
24th Apr 20237:01 amRNSBoard Changes
24th Apr 20237:00 amRNSTrading Update
17th Apr 20237:00 amRNSDirectors' Dealings
17th Apr 20237:00 amRNSShare Awards and Exercise of Options
14th Apr 202311:01 amRNSDirectors' Dealings and Holdings in Company
11th Apr 20233:08 pmRNSDirectors' Dealings
5th Apr 20234:13 pmRNSDirectors' Dealings
3rd Apr 20237:00 amRNSDirectors' Dealings
30th Mar 20238:56 amRNSDirectors’ Dealings
27th Mar 20233:26 pmRNSDirectors’ Dealings
27th Mar 20237:00 amRNSAnnual Report, Notice of Q1 Update, AGM & Dividend
22nd Mar 20231:35 pmRNSDirectors’ Dealings
17th Mar 20234:00 pmRNSHolding(s) in Company
17th Mar 20237:00 amRNSDirectors’ Dealings
16th Mar 20237:00 amRNSHolding(s) in Company
14th Mar 20237:00 amRNSDirectors' Dealings
10th Mar 20237:15 amEQSCentralNic (CNIC): Clarifying the narrative
9th Mar 20237:00 amRNSDirectors’ Dealings
6th Mar 20237:00 amRNSDirectors' Dealings
2nd Mar 20237:00 amRNSCentralNic among FT's fastest growing in Europe
27th Feb 20237:00 amRNSUnaudited Preliminary Accounts for Full Year 2022
31st Jan 20237:00 amRNSPartnership Announcement
30th Jan 20237:00 amRNSTrading Update, Board Changes, Notice of Results
25th Jan 20238:08 amRNSDirectors' Dealings
23rd Jan 20237:00 amRNSDirector Dealings
20th Jan 20237:00 amRNSNotification of Major Holdings
20th Jan 20237:00 amRNSDirectors' Dealings
19th Jan 20237:00 amRNSTransaction in Own Shares
17th Jan 20237:00 amRNSDirectors' Dealings
17th Jan 20237:00 amRNSTransaction in Own Shares
16th Jan 20237:00 amRNSTransaction in Own Shares
13th Jan 20237:00 amRNSTransaction in Own Shares
12th Jan 20238:14 amRNSDirectors' Dealings
12th Jan 20237:00 amRNSTransaction in Own Shares
11th Jan 20237:00 amRNSTransaction in Own Shares
10th Jan 20237:00 amRNSTransaction in Own Shares
10th Jan 20237:00 amRNSHolding(s) in Company
9th Jan 20234:17 pmRNSDirectors' Dealings
9th Jan 20237:00 amRNSTransaction in Own Shares
6th Jan 20238:13 amRNSShare Awards and exercise of Options
6th Jan 20237:00 amRNSTransaction in Own Shares
5th Jan 20237:00 amRNSTransaction in Own Shares
4th Jan 20237:00 amRNSTransaction in Own Shares
3rd Jan 20237:00 amRNSDirectors' Dealings
3rd Jan 20237:00 amRNSTransaction in Own Shares
30th Dec 20227:00 amRNSShare Buyback Programme
21st Dec 20226:17 pmRNSDirectors' Dealings
19th Dec 20227:00 amRNSAcquisition Announcement
16th Dec 20225:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.